Recently, a neoepitope (CLAVEEVSL) from NPM1c has been identified from HLA-A*02:01+ AML patients using tandem liquid chromatography-mass spectrometry (LC–MS/MS) technique, and then CD8+ T cells specific to this neoepitope have been isolated from healthy individuals. Here, HLA-A is linked to acute myeloid leukemia.